Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive

Hung-Hao Lee1, Tsung-Hsien Lin2, Ho-Ming Su2

  • 1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital;

Insights

Coronary ectasia with large thrombus burden can resist standard acute myocardial infarction treatments. Long-term warfarin combined with antiplatelet therapy may restore blood flow when other methods fail.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Coronary ectasia (CE) is an uncommon condition often associated with coronary artery stenosis.
  • Acute myocardial infarction (AMI) in CE patients presents unique challenges due to potential large thrombus burden.
  • Standard AMI treatments may be insufficient for CE patients with significant thrombotic load.

Observation:

  • A patient with CE experienced two episodes of AMI within two weeks.
  • Initial percutaneous coronary intervention with aspiration thrombectomy failed to restore adequate blood flow.
  • Pharmacological management with heparin, antiplatelets, and glycoprotein IIb/IIIa inhibitors yielded poor results.

Findings:

  • The patient was subsequently treated with dual antiplatelet therapy plus warfarin.
  • Follow-up angiography demonstrated restored TIMI 3 flow, indicating successful blood flow restoration.
  • This suggests a potential benefit of long-term anticoagulation in specific CE cases.

Implications:

  • For CE patients with large thrombus burden unresponsive to standard AMI treatment, long-term warfarin combined with antiplatelet therapy is a viable alternative.
  • This therapeutic approach may effectively reduce thrombus burden and improve coronary blood flow.
  • Further research is warranted to validate this treatment strategy for coronary ectasia.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
633
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
655